HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

MIB-1 counting methods in meningiomas and agreement among pathologists.

AbstractOBJECTIVE:
To evaluate the correlation of MIB-1 labeling index (LI) obtained by 2 counting methods with histologic grade and investigate interobserver variability between these methods.
STUDY DESIGN:
A total of 65 meningiomas were analyzed for proliferation with 2 counting methods by 2 pathologists using MIB-1 antibody. In the first method, the most densely staining areas were counted (HL method). In the second method, randomly selected areas were counted (RS method).
RESULTS:
MIB-1 values correlated well with histologic grade in both methods. As expected, the tumors with recurrence had significantly higher LIs than the nonrecurrent tumors in each method. However, there was a statistically significant difference in the mean MIB-1 values of between the HL and RS methods. When MIB-1 LI was compared between 2 pathologists, perfect agreement in the HL method and substantial agreement in the RS method were achieved.
CONCLUSION:
Our results showed that values of MIB LIs differ with different counting methods. Nonetheless, both methods showed good correlation with World Health Organization grades. Therefore standardization of 1 counting method is of great importance for determining a reliable and specific cutoff value in assessing the risk of recurrence in meningiomas.
AuthorsTurkan Rezanko, Asli Kahraman Akkalp, Mine Tunakan, Aysegul Akder Sari
JournalAnalytical and quantitative cytology and histology (Anal Quant Cytol Histol) Vol. 30 Issue 1 Pg. 47-52 (Feb 2008) United States
PMID18459587 (Publication Type: Evaluation Study, Journal Article)
Chemical References
  • Antibodies, Antinuclear
  • Antibodies, Monoclonal
  • Ki-67 Antigen
  • MIB-1 antibody
Topics
  • Antibodies, Antinuclear
  • Antibodies, Monoclonal
  • Humans
  • Ki-67 Antigen (analysis)
  • Meningeal Neoplasms (diagnosis, pathology)
  • Meningioma (diagnosis, pathology)
  • Neoplasm Recurrence, Local
  • Observer Variation
  • Prognosis
  • Reproducibility of Results
  • Sensitivity and Specificity

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: